Marcela de Lima Moreira
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Marcela de Lima Moreira has a total of 277 co-authors. Here are the top co-authors by number of shared publications:
Hyun Jae Lee
Department of Microbiology and Immunology, Faculty of Medicine, Dentistry and Health Sciences, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia
7 shared publications- Ashraful Haque
Department of Microbiology and Immunology, University of Melbourne, located at the Peter Doherty Institute for Infection and Immunity, Parkville, VIC 3000, Australia
6 shared publications Cameron G. Williams
Department of Microbiology and Immunology, Faculty of Medicine, Dentistry and Health Sciences, Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, VIC, Australia
5 shared publications- James McCluskey
Department of Microbiology & Immunology, University of Melbourne, Peter Doherty Institute for Infection and Immunity, Parkville, Victoria, Australia
5 shared publications - Olindo Assis Martins-Filho
Fundação Oswaldo Cruz, Brasil
5 shared publications - Sidonia Barbara Guiomar Eckle
University of Melbourne
5 shared publications
Latest Publications
- 15 October 2026
- Published by American Society of Hematology in Blood
- Vol. 148 (16) , 2059-2071
IL-6 receptor inhibition promotes expansion of cytolytic CD4+ T cells after cellular immunotherapy
Graft-versus-host disease (GVHD) remains a major barrier to the success of allogeneic hematopoietic stem cell transplantation (HSCT). In preclinical models, the dysregulation of interleukin-6 (IL-6) in the peritransplant period promotes GVHD via STAT3-dependent T-cell differentiation and monocyte activation, but the nature of immunological effects invoked in patients remains unclear. To advance our understanding of IL-6 signaling in humans during HSCT, we performed single-cell RNA sequencing on circulating CD14+ monocytes and CD4+ T cells from patient samples within a clinical trial of IL-6 receptor (IL-6R) inhibition (tocilizumab [TCZ] or placebo) on a backbone of calcineurin inhibition and short-course methotrexate. We studied patients who did not develop acute GVHD (aGVHD) and included a placebo-treated group analyzed before the development of aGVHD. IL-6R inhibition promoted type I interferon–associated transcriptional programs in both CD4+ T cells and CD14+ monocytes. Surprisingly, IL-6R inhibition with TCZ profoundly enhanced cytolytic CD4+ T-cell differentiation. In experimental HSCT and chimeric antigen receptor T-cell systems, the genetic deletion of IL-6 signaling in donor T cells enhanced the expansion of cytolytic eomesodermin-positive (Eomes+) CD4+ regulatory T cell subsets and attenuated T helper 1 (Th1) and Th17 differentiation. Consistent with the promotion of this cytolytic CD4+ phenotype, antitumor effects were improved in the absence of IL-6 signaling. In summary, these data demonstrate that IL-6R inhibition during cell therapy imprints type I interferon programs and cytolytic CD4+ T-cell differentiation, including the Eomes+ fraction associated with favorable immunotherapy outcomes.
- 15 October 2026
- Published by American Society of Hematology in Blood
- Vol. 148 (16) , 2059-2071
IL-6 receptor inhibition promotes expansion of cytolytic CD4+ T cells after cellular immunotherapy
Graft-versus-host disease (GVHD) remains a major barrier to the success of allogeneic hematopoietic stem cell transplantation (HSCT). In preclinical models, the dysregulation of interleukin-6 (IL-6) in the peritransplant period promotes GVHD via STAT3-dependent T-cell differentiation and monocyte activation, but the nature of immunological effects invoked in patients remains unclear. To advance our understanding of IL-6 signaling in humans during HSCT, we performed single-cell RNA sequencing on circulating CD14+ monocytes and CD4+ T cells from patient samples within a clinical trial of IL-6 receptor (IL-6R) inhibition (tocilizumab [TCZ] or placebo) on a backbone of calcineurin inhibition and short-course methotrexate. We studied patients who did not develop acute GVHD (aGVHD) and included a placebo-treated group analyzed before the development of aGVHD. IL-6R inhibition promoted type I interferon–associated transcriptional programs in both CD4+ T cells and CD14+ monocytes. Surprisingly, IL-6R inhibition with TCZ profoundly enhanced cytolytic CD4+ T-cell differentiation. In experimental HSCT and chimeric antigen receptor T-cell systems, the genetic deletion of IL-6 signaling in donor T cells enhanced the expansion of cytolytic eomesodermin-positive (Eomes+) CD4+ regulatory T cell subsets and attenuated T helper 1 (Th1) and Th17 differentiation. Consistent with the promotion of this cytolytic CD4+ phenotype, antitumor effects were improved in the absence of IL-6 signaling. In summary, these data demonstrate that IL-6R inhibition during cell therapy imprints type I interferon programs and cytolytic CD4+ T-cell differentiation, including the Eomes+ fraction associated with favorable immunotherapy outcomes.
- 15 June 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (7) , 1502-1516
A temporal map of B cell diversification mechanisms in mice
Naive B cells diversify via clonal expansion, immunoglobulin isotype switching, phenotypic variation and somatic hypermutation (SHM). Diversity in antigenic targets, functional classes and the production kinetics of antibodies affects immunity to malaria. Here we show that individual clones diversify over time during Plasmodium infection. During the first week, amid widespread bystander activation, isotype switching initiates soon after Myc upregulation and overlaps with clonal expansion, resulting in isotype variegation among clones. During the second week, expanded clones seeding germinal centers (GC) bifurcate into extrafollicular plasmablasts, exhibit isotype variegation and initiate SHM, indicating substantial intraclonal diversification. Over the following month, GC clones exhibit SHM at approximately four mutations per week. Antimalarial intervention does not impede SHM, instead exerting quantitative limits on GC size, plasma cell emergence, circulating antibody levels and protection against reinfection. Finally, contemporaneous B cell development relocates from bone marrow to spleen. Thus, multiple temporally overlapping mechanisms combine in vivo to diversify and safeguard humoral immune responses.
- 15 June 2026
- Published by Springer Nature in Nature Immunology
- Vol. 27 (7) , 1502-1516
A temporal map of B cell diversification mechanisms in mice
Naive B cells diversify via clonal expansion, immunoglobulin isotype switching, phenotypic variation and somatic hypermutation (SHM). Diversity in antigenic targets, functional classes and the production kinetics of antibodies affects immunity to malaria. Here we show that individual clones diversify over time during Plasmodium infection. During the first week, amid widespread bystander activation, isotype switching initiates soon after Myc upregulation and overlaps with clonal expansion, resulting in isotype variegation among clones. During the second week, expanded clones seeding germinal centers (GC) bifurcate into extrafollicular plasmablasts, exhibit isotype variegation and initiate SHM, indicating substantial intraclonal diversification. Over the following month, GC clones exhibit SHM at approximately four mutations per week. Antimalarial intervention does not impede SHM, instead exerting quantitative limits on GC size, plasma cell emergence, circulating antibody levels and protection against reinfection. Finally, contemporaneous B cell development relocates from bone marrow to spleen. Thus, multiple temporally overlapping mechanisms combine in vivo to diversify and safeguard humoral immune responses.
- Open Access
- 29 December 2025
- Published by Springer Nature in Nature Immunology
- Vol. 27 (1) , 98-109
Antigen reactivity defines tissue-resident memory and exhausted T cells in tumors
CD8 + T cells are an important weapon in the therapeutic armamentarium against cancer. While CD8 + CD103 + T cells with a tissue-resident memory T (T RM ) cell phenotype are associated with favorable prognoses, the tumor microenvironment also contains dysfunctional exhausted T (T EX ) cells that exhibit a variety of T RM -like features. Here we deconvolute T RM and T EX cells across human cancers, ascribing markers and gene signatures that distinguish these populations and enable their functional distinction. Although T RM cells have superior functionality and are associated with long-term survival post-tumor resection, they are not associated with responsiveness to immune checkpoint blockade. Tumor-associated T EX and T RM cells are clonally distinct, with the latter comprising tumor-independent bystanders and tumor-specific cells segregated from cognate antigen. Intratumoral T RM cells can be forced toward an exhausted fate when chronic antigen stimulation occurs, indicating that the presence or absence of continuous antigen exposure within the microenvironment is the key distinction between tumor-associated T EX and T RM populations. These results highlight unique functions for T RM and T EX cells in tumor control, underscoring the need for distinct strategies to harness these populations for cancer therapies.
- 29 December 2025
- Published by Springer Nature in Nature Immunology
- Vol. 27 (1) , 98-109
Open AccessAntigen reactivity defines tissue-resident memory and exhausted T cells in tumors
CD8 + T cells are an important weapon in the therapeutic armamentarium against cancer. While CD8 + CD103 + T cells with a tissue-resident memory T (T RM ) cell phenotype are associated with favorable prognoses, the tumor microenvironment also contains dysfunctional exhausted T (T EX ) cells that exhibit a variety of T RM -like features. Here we deconvolute T RM and T EX cells across human cancers, ascribing markers and gene signatures that distinguish these populations and enable their functional distinction. Although T RM cells have superior functionality and are associated with long-term survival post-tumor resection, they are not associated with responsiveness to immune checkpoint blockade. Tumor-associated T EX and T RM cells are clonally distinct, with the latter comprising tumor-independent bystanders and tumor-specific cells segregated from cognate antigen. Intratumoral T RM cells can be forced toward an exhausted fate when chronic antigen stimulation occurs, indicating that the presence or absence of continuous antigen exposure within the microenvironment is the key distinction between tumor-associated T EX and T RM populations. These results highlight unique functions for T RM and T EX cells in tumor control, underscoring the need for distinct strategies to harness these populations for cancer therapies.
- 31 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (112) , eadw1992
Stem-like tissue-resident memory T cells control functional heterogeneity and reactivation of T cell memory in the intestine
Tissue-resident memory T (T RM ) cells provide localized immunity against intracellular pathogens and cancer. Upon antigen reencounter, T RM cells differentiate into effector cells while also giving rise to another generation of memory cells. Here, we show that intestinal T RM cells that express the transcriptional regulators TCF1 or ID3 exhibit stem-like memory properties and are endowed with a superior capacity to regenerate effector and memory T cells after pathogen reencounter. Ablation of TCF1 using a T RM cell–specific mouse model resulted in impaired formation of intestinal T RM cells, altered their transcriptional heterogeneity, and increased their differentiation into tissue-confined and recirculating CX3CR1 + effector cells during recall. TGF-β and retinoic acid were required for formation and survival of TCF1- and ID3-expressing T RM cells and restrained their differentiation into CX3CR1 + effector cells during reinfection. Thus, stem-like cells control the quality and recall capacity of T RM cells, thereby contributing to anamnestic memory responses.
- 31 October 2025
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 10 (112) , eadw1992
Stem-like tissue-resident memory T cells control functional heterogeneity and reactivation of T cell memory in the intestine
Tissue-resident memory T (T RM ) cells provide localized immunity against intracellular pathogens and cancer. Upon antigen reencounter, T RM cells differentiate into effector cells while also giving rise to another generation of memory cells. Here, we show that intestinal T RM cells that express the transcriptional regulators TCF1 or ID3 exhibit stem-like memory properties and are endowed with a superior capacity to regenerate effector and memory T cells after pathogen reencounter. Ablation of TCF1 using a T RM cell–specific mouse model resulted in impaired formation of intestinal T RM cells, altered their transcriptional heterogeneity, and increased their differentiation into tissue-confined and recirculating CX3CR1 + effector cells during recall. TGF-β and retinoic acid were required for formation and survival of TCF1- and ID3-expressing T RM cells and restrained their differentiation into CX3CR1 + effector cells during reinfection. Thus, stem-like cells control the quality and recall capacity of T RM cells, thereby contributing to anamnestic memory responses.
- 27 October 2025
- Published by Springer Nature in Nature Immunology
- Vol. 26 (12) , 2312-2327
Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer
CD8+ T cells are major mediators of antiviral and antitumor immunity. During persistent antigen stimulation as in chronic infection and cancer, however, they differentiate into exhausted T cells that display impaired functionality. Precursors of exhausted T (TPEX) cells exhibit stem-like properties, including high proliferative, self-renewal and developmental potential, and are responsible for long-term CD8+ T cell responses against persistent antigens. Here we identify the chromatin organizer and transcriptional regulator SATB1 as a major regulator of exhausted CD8+ T cell differentiation. SATB1 was specifically expressed in TPEX cells where it limited population expansion and effector differentiation while preserving functionality of CD8+ T cells. SATB1 downregulation was required for TPEX cell-to-effector cell differentiation in chronic infection and contributed to coordinated effector and memory differentiation in acute viral infection. DNA binding of SATB1 regulated gene expression both dependent and independent of chromatin accessibility. Finally, SATB1 limited antitumor CD8+ and chimeric antigen receptor T cell immunity. Overall, our results identify SATB1 as a central regulator of precursor fate and effector differentiation of CD8+ T cells both in infection and in cancer.
- 27 October 2025
- Published by Springer Nature in Nature Immunology
- Vol. 26 (12) , 2312-2327
Transcriptional regulator SATB1 limits CD8+ T cell population expansion and effector differentiation in chronic infection and cancer
CD8+ T cells are major mediators of antiviral and antitumor immunity. During persistent antigen stimulation as in chronic infection and cancer, however, they differentiate into exhausted T cells that display impaired functionality. Precursors of exhausted T (TPEX) cells exhibit stem-like properties, including high proliferative, self-renewal and developmental potential, and are responsible for long-term CD8+ T cell responses against persistent antigens. Here we identify the chromatin organizer and transcriptional regulator SATB1 as a major regulator of exhausted CD8+ T cell differentiation. SATB1 was specifically expressed in TPEX cells where it limited population expansion and effector differentiation while preserving functionality of CD8+ T cells. SATB1 downregulation was required for TPEX cell-to-effector cell differentiation in chronic infection and contributed to coordinated effector and memory differentiation in acute viral infection. DNA binding of SATB1 regulated gene expression both dependent and independent of chromatin accessibility. Finally, SATB1 limited antitumor CD8+ and chimeric antigen receptor T cell immunity. Overall, our results identify SATB1 as a central regulator of precursor fate and effector differentiation of CD8+ T cells both in infection and in cancer.
- 15 September 2025
- Published by Springer Nature in Nature Immunology
- Vol. 26 (10) , 1752-1765
Lymph nodes fuel KLF2-dependent effector CD8+ T cell differentiation during chronic infection and checkpoint blockade
Exhausted CD8+ T (TEX) cell responses are maintained by precursors of exhausted T (TPEX) cells that possess high self-renewal and developmental potential. TPEX cells also drive the proliferative burst of effector T cells upon therapeutic immune checkpoint blockade (ICB). However, the spatial context and signals that regulate their differentiation and function are not well defined. Here we identify developmental and functional compartmentalization of TPEX and TEX cells across secondary lymphoid organs during chronic infection. We show that stem-like CD62L+ TPEX and effector-like CX3CR1+ TEX cells constitute a distinct developmental lineage that is promoted by the lymph node (LN) microenvironment and dependent on the transcription factor KLF2. LNs act as a niche in which migratory dendritic cells provide antigen and costimulatory signals to maintain the proliferative fitness of CD62L+ TPEX cells and generation of CX3CR1+ TEX cells. Moreover, LNs exclusively drive the proliferative burst and systemic dissemination of CX3CR1+ TEX cells during ICB. Thus, our findings identify a unique role for LNs in the maintenance of T cell differentiation and function during systemic chronic infection and ICB therapy.
- 15 September 2025
- Published by Springer Nature in Nature Immunology
- Vol. 26 (10) , 1752-1765
Lymph nodes fuel KLF2-dependent effector CD8+ T cell differentiation during chronic infection and checkpoint blockade
Exhausted CD8+ T (TEX) cell responses are maintained by precursors of exhausted T (TPEX) cells that possess high self-renewal and developmental potential. TPEX cells also drive the proliferative burst of effector T cells upon therapeutic immune checkpoint blockade (ICB). However, the spatial context and signals that regulate their differentiation and function are not well defined. Here we identify developmental and functional compartmentalization of TPEX and TEX cells across secondary lymphoid organs during chronic infection. We show that stem-like CD62L+ TPEX and effector-like CX3CR1+ TEX cells constitute a distinct developmental lineage that is promoted by the lymph node (LN) microenvironment and dependent on the transcription factor KLF2. LNs act as a niche in which migratory dendritic cells provide antigen and costimulatory signals to maintain the proliferative fitness of CD62L+ TPEX cells and generation of CX3CR1+ TEX cells. Moreover, LNs exclusively drive the proliferative burst and systemic dissemination of CX3CR1+ TEX cells during ICB. Thus, our findings identify a unique role for LNs in the maintenance of T cell differentiation and function during systemic chronic infection and ICB therapy.
- 6 December 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (102) , eadp9841
MAIT cell plasticity enables functional adaptation that drives antibacterial immune protection
Mucosal-associated invariant T (MAIT) cells are known for their rapid effector functions and antibacterial immune protection. Here, we define the plasticity of interferon-γ (IFN-γ)–producing MAIT1 and interleukin-17A (IL-17A)–producing MAIT17 cell subsets in vivo. Whereas T-bet + MAIT1 cells remained stable in all experimental settings, after adoptive transfer or acute Legionella or Francisella infection, RORγt + MAIT17 cells could undergo phenotypic and functional conversion into both RORγt + T-bet + MAIT1/17 and RORγt − T-bet + MAIT1 cells. This plasticity ensured that MAIT17 cells played a dominant role in generating antibacterial MAIT1 responses in mucosal tissues. Single-cell transcriptomics revealed that MAIT17-derived MAIT1 cells were distinct from canonical MAIT1 cells yet could migrate out of mucosal tissues to contribute to the global MAIT1 pool in subsequent systemic infections. Human IL-17A–secreting MAIT cells also showed similar functional plasticity. Our findings have broad implications for understanding the role of MAIT cells in combatting infections and their potential utility in MAIT cell–targeted vaccines.
- 6 December 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (102) , eadp9841
MAIT cell plasticity enables functional adaptation that drives antibacterial immune protection
Mucosal-associated invariant T (MAIT) cells are known for their rapid effector functions and antibacterial immune protection. Here, we define the plasticity of interferon-γ (IFN-γ)–producing MAIT1 and interleukin-17A (IL-17A)–producing MAIT17 cell subsets in vivo. Whereas T-bet + MAIT1 cells remained stable in all experimental settings, after adoptive transfer or acute Legionella or Francisella infection, RORγt + MAIT17 cells could undergo phenotypic and functional conversion into both RORγt + T-bet + MAIT1/17 and RORγt − T-bet + MAIT1 cells. This plasticity ensured that MAIT17 cells played a dominant role in generating antibacterial MAIT1 responses in mucosal tissues. Single-cell transcriptomics revealed that MAIT17-derived MAIT1 cells were distinct from canonical MAIT1 cells yet could migrate out of mucosal tissues to contribute to the global MAIT1 pool in subsequent systemic infections. Human IL-17A–secreting MAIT cells also showed similar functional plasticity. Our findings have broad implications for understanding the role of MAIT cells in combatting infections and their potential utility in MAIT cell–targeted vaccines.
- Open Access
- 28 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
CD4+ T cells display a spectrum of recall dynamics during re-infection with malaria parasites
Children in malaria-endemic regions can experience repeated Plasmodium infections over short periods of time. Effects of re-infection on multiple co-existing CD4+ T cell subsets remain unresolved. Here, we examine antigen-experienced CD4+ T cells during re-infection in mice, using scRNA-seq/TCR-seq and spatial transcriptomics. TCR transgenic TEM cells initiate rapid Th1/Tr1 recall responses prior to proliferating, while GC Tfh counterparts are refractory, with TCM/Tfh-like cells exhibiting modest non-proliferative responses. Th1-recall is a partial facsimile of primary Th1-responses, with no upregulated effector-associated genes being unique to recall. Polyclonal, TCR-diverse, CD4+ T cells exhibit similar recall dynamics, with individual clones giving rise to multiple effectors including highly proliferative Th1/Tr1 cells, as well as GC Tfh and Tfh-like cells lacking proliferative capacity. Thus, we show substantial diversity in recall responses mounted by multiple co-existing CD4+ T cell subsets in the spleen, and present graphical user interfaces for studying gene expression dynamics and clonal relationships during re-infection.
- 28 June 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-18
Open AccessCD4+ T cells display a spectrum of recall dynamics during re-infection with malaria parasites
Children in malaria-endemic regions can experience repeated Plasmodium infections over short periods of time. Effects of re-infection on multiple co-existing CD4+ T cell subsets remain unresolved. Here, we examine antigen-experienced CD4+ T cells during re-infection in mice, using scRNA-seq/TCR-seq and spatial transcriptomics. TCR transgenic TEM cells initiate rapid Th1/Tr1 recall responses prior to proliferating, while GC Tfh counterparts are refractory, with TCM/Tfh-like cells exhibiting modest non-proliferative responses. Th1-recall is a partial facsimile of primary Th1-responses, with no upregulated effector-associated genes being unique to recall. Polyclonal, TCR-diverse, CD4+ T cells exhibit similar recall dynamics, with individual clones giving rise to multiple effectors including highly proliferative Th1/Tr1 cells, as well as GC Tfh and Tfh-like cells lacking proliferative capacity. Thus, we show substantial diversity in recall responses mounted by multiple co-existing CD4+ T cell subsets in the spleen, and present graphical user interfaces for studying gene expression dynamics and clonal relationships during re-infection.
- 19 January 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (91) , eadi9517
CD4 + T cell immunity against cutaneous melanoma encompasses multifaceted MHC II–dependent responses
Whereas CD4 + T cells conventionally mediate antitumor immunity by providing help to CD8 + T cells, recent clinical studies have implied an important role for cytotoxic CD4 + T cells in cancer immunity. Using an orthotopic melanoma model, we provide a detailed account of antitumoral CD4 + T cell responses and their regulation by major histocompatibility complex class II (MHC II) in the skin. Intravital imaging revealed prominent interactions of CD4 + T cells with tumor debris-laden MHC II + host antigen-presenting cells that accumulated around tumor cell nests, although direct recognition of MHC II + melanoma cells alone could also promote CD4 + T cell control. CD4 + T cells stably suppressed or eradicated tumors even in the absence of other lymphocytes by using tumor necrosis factor–α and Fas ligand (FasL) but not perforin-mediated cytotoxicity. Interferon-γ was critical for protection, acting both directly on melanoma cells and via induction of nitric oxide synthase in myeloid cells. Our results illustrate multifaceted and context-specific aspects of MHC II–dependent CD4 + T cell immunity against cutaneous melanoma, emphasizing modulation of this axis as a potential avenue for immunotherapies.
- 19 January 2024
- Published by American Association for the Advancement of Science (AAAS) in Science Immunology
- Vol. 9 (91) , eadi9517
CD4 + T cell immunity against cutaneous melanoma encompasses multifaceted MHC II–dependent responses
Whereas CD4 + T cells conventionally mediate antitumor immunity by providing help to CD8 + T cells, recent clinical studies have implied an important role for cytotoxic CD4 + T cells in cancer immunity. Using an orthotopic melanoma model, we provide a detailed account of antitumoral CD4 + T cell responses and their regulation by major histocompatibility complex class II (MHC II) in the skin. Intravital imaging revealed prominent interactions of CD4 + T cells with tumor debris-laden MHC II + host antigen-presenting cells that accumulated around tumor cell nests, although direct recognition of MHC II + melanoma cells alone could also promote CD4 + T cell control. CD4 + T cells stably suppressed or eradicated tumors even in the absence of other lymphocytes by using tumor necrosis factor–α and Fas ligand (FasL) but not perforin-mediated cytotoxicity. Interferon-γ was critical for protection, acting both directly on melanoma cells and via induction of nitric oxide synthase in myeloid cells. Our results illustrate multifaceted and context-specific aspects of MHC II–dependent CD4 + T cell immunity against cutaneous melanoma, emphasizing modulation of this axis as a potential avenue for immunotherapies.
- Open Access
- 16 July 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-15
Francisella tularensis induces Th1 like MAIT cells conferring protection against systemic and local infection
Mucosal-associated Invariant T (MAIT) cells are recognized for their antibacterial functions. The protective capacity of MAIT cells has been demonstrated in murine models of local infection, including in the lungs. Here we show that during systemic infection of mice with Francisella tularensis live vaccine strain results in evident MAIT cell expansion in the liver, lungs, kidney and spleen and peripheral blood. The responding MAIT cells manifest a polarised Th1-like MAIT-1 phenotype, including transcription factor and cytokine profile, and confer a critical role in controlling bacterial load. Post resolution of the primary infection, the expanded MAIT cells form stable memory-like MAIT-1 cell populations, suggesting a basis for vaccination. Indeed, a systemic vaccination with synthetic antigen 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil in combination with CpG adjuvant similarly boosts MAIT cells, and results in enhanced protection against both systemic and local infections with different bacteria. Our study highlights the potential utility of targeting MAIT cells to combat a range of bacterial pathogens.
- 16 July 2021
- Published by Springer Nature in Nature Communications
- Vol. 12 (1) , 1-15
Open AccessFrancisella tularensis induces Th1 like MAIT cells conferring protection against systemic and local infection
Mucosal-associated Invariant T (MAIT) cells are recognized for their antibacterial functions. The protective capacity of MAIT cells has been demonstrated in murine models of local infection, including in the lungs. Here we show that during systemic infection of mice with Francisella tularensis live vaccine strain results in evident MAIT cell expansion in the liver, lungs, kidney and spleen and peripheral blood. The responding MAIT cells manifest a polarised Th1-like MAIT-1 phenotype, including transcription factor and cytokine profile, and confer a critical role in controlling bacterial load. Post resolution of the primary infection, the expanded MAIT cells form stable memory-like MAIT-1 cell populations, suggesting a basis for vaccination. Indeed, a systemic vaccination with synthetic antigen 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil in combination with CpG adjuvant similarly boosts MAIT cells, and results in enhanced protection against both systemic and local infections with different bacteria. Our study highlights the potential utility of targeting MAIT cells to combat a range of bacterial pathogens.